PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,708,005 | +32.6% | 510,555 | 0.0% | 0.38% | +40.1% |
| Q4 2022 | $4,303,979 | -49.4% | 510,555 | 0.0% | 0.27% | -33.7% |
| Q3 2022 | $8,506,000 | +13.2% | 510,555 | 0.0% | 0.41% | +9.7% |
| Q2 2022 | $7,515,000 | -26.1% | 510,555 | +24.5% | 0.37% | -31.1% |
| Q1 2022 | $10,176,000 | +28.4% | 410,155 | +66.0% | 0.54% | +43.2% |
| Q4 2021 | $7,923,000 | -10.9% | 247,047 | 0.0% | 0.38% | -18.5% |
| Q3 2021 | $8,889,000 | +7.7% | 247,047 | +32.1% | 0.46% | +25.7% |
| Q2 2021 | $8,253,000 | -3.5% | 187,047 | 0.0% | 0.37% | +3.7% |
| Q1 2021 | $8,556,000 | -33.7% | 187,047 | 0.0% | 0.35% | -36.2% |
| Q4 2020 | $12,910,000 | – | 187,047 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |